Development of inactivated poliovirus vaccine derived from Sabin strains

被引：39

作者：

Simizu, B ^{[1
]}

Abe, S ^{[1
]}

Yamamoto, H ^{[1
]}

Tano, Y ^{[1
]}

Ota, Y ^{[1
]}

Miyazawa, M ^{[1
]}

Horie, H ^{[1
]}

Satoh, K ^{[1
]}

Wakabayashi, K ^{[1
]}

机构：

[1] Japan Poliomyelitis Res Inst, Tokyo 1890003, Japan

来源：

BIOLOGICALS | 2006年 / 34卷 / 02期

关键词：

IPV; Sabin strains; D-antigen; immunogenicity;

D O I：

10.1016/j.biologicals.2006.02.010

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

In the course of Sabin-inactivated poliovirus vaccine (S-IPV) development, we have established high-yield virus production techniques based on Vero cell micro-carrier cultures. Development of specific ELISA tests to quantify the antigen content of S-IPV has been achieved. To adjust the immunogenicity of S-IPV so as to be comparable with the conventional-IPV, a new formulation was determined using a potency test using rats. The reformulated S-IPV was shown to be efficacious for the immunization of monkeys. (c) 2006 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.

引用

页码：151 / 154

页数：4

共 50 条

[21] Change from oral poliovirus vaccine to inactivated poliovirus vaccine
Mele, A
Jefferson, T
Franco, E
Salmaso, S
LANCET, 2002, 360 (9340): : 1178 - 1178
[22] 1ST CLINICAL-TRIAL WITH SABIN INACTIVATED POLIOVIRUS VACCINE
MURPH, JR
GROSE, C
CUTHBERTSON, G
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1987, 141 (04): : 381 - 381
[23] Phase 3 Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine
Liao, Guoyang
Li, Rongcheng
Li, Changgui
Sun, Mingbo
Jiang, Shude
Li, Yanping
Mo, Zhaojun
Xia, Jielai
Xie, Zhongping
Che, Yanchun
Yang, Jingsi
Yin, Zhifang
Wang, Jianfeng
Chu, Jiayou
Cai, Wei
Zhou, Jian
Wang, Junzhi
Li, Qihan
JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (11): : 1728 - 1734
[24] EVALUATION OF SABIN LIVE POLIOVIRUS VACCINE IN JAPAN .V. NEUROVIRULENCE OF VIRUS STRAINS DERIVED FROM VACCINEES AND THEIR CONTACTS
EGASHIRA, Y
UCHIDA, N
SHIMOJO, H
JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1967, 20 (04): : 281 - &
[25] PERSISTENCE OF ANTIBODY AFTER ORAL TRIVALENT POLIOVIRUS VACCINE ( SABIN STRAINS )
CABASSO, VJ
COX, HR
RUEGSEGGER, JM
NOZELL, H
NEW ENGLAND JOURNAL OF MEDICINE, 1964, 270 (09): : 443 - &
[26] A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
Nakano, Takashi
Sumino, Shuji
Takanami, Yohei
Mitsuya, Nodoka
Nakatome, Keisuke
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 2940 - 2949
[27] Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains
Tang, Rong
Chu, Kai
Hu, Yuansheng
Chen, Lei
Zhang, Ming
Liu, Sheng
Ma, Hui
Wang, Jianfeng
Zhu, Fengcai
Hu, Yuemei
Gao, Qiang
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1160 - 1166
[28] Immune persistence of an inactivated poliovirus vaccine derived from the Sabin strain: a 10-year follow-up of a phase 3
Ma, Lei
Ying, Zhifang
Cai, Wei
Wang, Jianfeng
Zhou, Jian
Yang, Huijuan
Gao, Jingxia
Zhao, Zhimei
Liu, Jing
Ouyang, Shengjie
Song, Shaohui
Shen, Fei
Zhao, Ruirui
Xu, Lilan
Dai, Xiaohu
Wu, Yanan
Li, Weidong
Li, Changgui
Liao, Guoyang
ECLINICALMEDICINE, 2023, 64
[29] Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains
Westdijk, Janny
Koedam, Patrick
Barro, Mario
Steil, Benjamin P.
Collin, Nicolas
Vedvick, Thomas S.
Bakker, Wilfried A. M.
van der Ley, Peter
Kersten, Gideon
VACCINE, 2013, 31 (09) : 1298 - 1304
[30] Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: A phase I trial in healthy adults
Verdijk, Pauline
Rots, Nynke Y.
van Oijen, Monique G. C. T.
Oberste, M. Steven
Boog, Claire J.
Okayasu, Hiromasa
Sutter, Roland W.
Bakker, Wilfried A. M.
VACCINE, 2013, 31 (47) : 5531 - 5536

← 1 2 3 4 5 →